Core IM | Internal Medicine Podcast cover image

#192 Debate on First-Line Medications for Diabetes

Core IM | Internal Medicine Podcast

00:00

Emerging GLP-1 Benefits for Liver Disease

Kenny highlights GLP-1 evidence for improving metabolic-associated steatohepatitis and potential fibrosis reduction.

Play episode from 34:52
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app